Gene · 23186
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RCOR1 is targeted by miR-23b-3p to modulate growth, colony formation, migration, and invasion of prostate cancer cells. | Int J Clin Exp Pathol | 2024 | 38455506 | PubTator, text mining | PubMed |
| The CoREST repressor complex mediates phenotype switching and therapy resistance in melanoma. | J Clin Invest | 2024 | 38300709 | PubTator, text mining | PubMed |
| Single-cell disulfidptosis regulator patterns guide intercellular communication of tumor microenvironment that contribute to kidney renal clear cell carcinoma progression and immunotherapy. | Front Immunol | 2024 | 38292868 | PubTator, text mining | PubMed |
| ZNF217: An Oncogenic Transcription Factor and Potential Therapeutic Target for Multiple Human Cancers. | Cancer Manag Res | 2024 | 38259608 | PubTator, text mining | PubMed |
| The Sensitization Profile for Selected Food Allergens in Polish Children Assessed with the Use of a Precision Allergy Molecular Diagnostic Technique. | Int J Mol Sci | 2024 | 38255900 | PubTator, text mining | PubMed |
| MDM2 Antagonist Idasanutlin Reduces HDAC1/2 Abundance and Corepressor Partners but Not HDAC3. | ACS Med Chem Lett | 2024 | 38229760 | PubTator, text mining | PubMed |
| A genome-wide association study of social trust in 33,882 Danish blood donors. | Sci Rep | 2024 | 38228779 | PubTator, text mining | PubMed |
| Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks. | J Exp Clin Cancer Res | 2024 | 38183103 | PubTator, text mining | PubMed |
| Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity Labeling. | Mol Cell Proteomics | 2024 | 38122900 | PubTator, text mining | PubMed |
| Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions. | Exp Hematol | 2024 | 38072133 | PubTator, text mining | PubMed |
| Comprehensive analysis of the proximity-dependent nuclear interactome for the oncoprotein NOTCH1 in live cells. | J Biol Chem | 2024 | 38043798 | PubTator, text mining | PubMed |
| SINE-Associated LncRNA SAWPA Regulates Porcine Zygotic Genome Activation. | Adv Sci (Weinh) | 2024 | 37984872 | PubTator, text mining | PubMed |
Defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma. | Transl Oncol | 2024 | 37865047 | PubTator, text mining | PubMed |
| Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson's disease and advanced therapeutic strategies. | Gene | 2024 | 37832803 | PubTator, text mining | PubMed |
| Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors. | SLAS Discov | 2024 | 37714432 | PubTator, text mining | PubMed |
| Inhibition of the CoREST Repressor Complex Promotes Wound Re-Epithelialization through the Regulation of Keratinocyte Migration. | J Invest Dermatol | 2024 | 37633457 | PubTator, text mining | PubMed |
| Metastasis and cancer associated fibroblasts: taking it up a NOTCH. | Front Cell Dev Biol | 2023 | 38269089 | PubTator, text mining | PubMed |
| Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. | Front Immunol | 2023 | 38268926 | PubTator, text mining | PubMed |
| Genetic Association and Differential RNA Expression of Histone (De)Acetylation-Related Genes in Pemphigus Foliaceus-A Possible Epigenetic Effect in the Autoimmune Response. | Life (Basel) | 2023 | 38255677 | PubTator, text mining | PubMed |
| The complex nature of lncRNA-mediated chromatin dynamics in multiple myeloma. | Front Oncol | 2023 | 38148842 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23186/papers?page=6